Previous close | 4.3000 |
Open | 4.3000 |
Bid | 1.1500 |
Ask | 4.9000 |
Strike | 380.00 |
Expiry date | 2024-01-19 |
Day's range | 4.3000 - 4.3000 |
Contract range | N/A |
Volume | |
Open interest | 1 |
BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of vaginitis.
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy.